Momota, Yuki
Bun, Shogyoku
Hirano, Jinichi
Kamiya, Kei
Ueda, Ryo
Iwabuchi, Yu
Takahata, Keisuke
Yamamoto, Yasuharu
Tezuka, Toshiki
Kubota, Masahito
Seki, Morinobu
Shikimoto, Ryo
Mimura, Yu
Kishimoto, Taishiro
Tabuchi, Hajime
Jinzaki, Masahiro
Ito, Daisuke
Mimura, Masaru
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19dm0307102, JP17pc0101006)
Article History
Received: 12 September 2023
Accepted: 26 March 2024
First Online: 1 April 2024
Competing interests
: The authors have no conflicts of interest relevant to the contents of this article. Within the past three years, Dr. Mimura has received grants and/or speaker's honoraria from Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, FRONTEO, FUJIFILM RI Pharma, Janssen Pharmaceutical, Mochida Pharmaceutical, MSD, Nippon Chemipher, Novartis Pharma, Ono Pharma, Otsuka Pharmaceutical, Pfizer, Takeda Pharma, Tsumura, and Yoshitomi Pharma.